GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Net Income Including Noncontrolling Interests

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Net Income Including Noncontrolling Interests : د.إ184 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Gulf Pharmaceutical Industries PSC's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was د.إ141 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was د.إ184 Mil.

Gulf Pharmaceutical Industries PSC Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Net Income Including Noncontrolling Interests Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -317.40 59.40 -31.70 -98.50 44.90

Gulf Pharmaceutical Industries PSC Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 -4.00 -5.10 52.40 141.10

Gulf Pharmaceutical Industries PSC Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ184 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gulf Pharmaceutical Industries PSC Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO SHSE:600998 TSE:7459 SHSE:600511 TSE:9987 TSE:2784 SHSE:600739 SHSE:600056 TSE:8129 SZSE:000028
Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Website
https://www.julphar.net
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Planet, Investments, and others. The majority of its revenue is generated from the planet segment. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC Headlines

No Headlines